Sources: 12Gene Ontology See all sources |
Cellular components related to nicotine dependence according to GeneDecks: (show all 13)
| id | Name | GO ID | Score | Top Affiliating Genes | | 1 | dendritic spine | GO:043197 | 9.8 | GABBR1, SLC1A3, DRD4, DRD1, APBB1 | | 2 | presynaptic membrane | GO:042734 | 9.7 | GRM2, APBB1, NRXN1, GABBR1 | | 3 | axon | GO:030424 | 9.7 | GABRA2, SLC6A3, DDC, DRD2, DRD1, GRM2 | | 4 | synapse | GO:045202 | 9.6 | CHRNB1, SLC1A3, NRXN1, DLG4, APBB1, GRIN3A | | 5 | acetylcholine-gated channel complex | GO:005892 | 9.5 | CHRNA3, CHRNB2, CHRNA1, CHRNA4, CHRNA2, CHRNA5 | | 6 | neuron projection | GO:043005 | 9.4 | GABBR2, TH, PTEN, TPH2, TPH1, GRIN3A | | 7 | terminal button | GO:043195 | 8.9 | SLC18A2, DBH, NTRK2, DRD4 | | 8 | postsynaptic density | GO:014069 | 8.9 | NTRK2, DLG4, DRD2, GRIN3A, CHRM1, CHRNA3 | | 9 | postsynaptic membrane | GO:045211 | 8.6 | CHRNA6, CHRNA7, CHRNA3, CHRM1, CHRNB2, CHRNA1 | | 10 | neuronal cell body | GO:043025 | 8.4 | DBH, SLC6A3, SLC1A3, SLC18A2, GABBR1, CHRNA5 | | 11 | cell junction | GO:030054 | 8.4 | CHRNA4, CHRNA9, CHRNB3, CHRNB1, CHRNA5, GRIN3A | | 12 | integral to plasma membrane | GO:005887 | 7.6 | SLC6A3, SLC6A4, SLC18A2, GABBR1, GABBR2, GABRA4 | | 13 | plasma membrane | GO:005886 | 4.6 | NCAM1, GRM2, APBB1, DRD1, DRD2, DRD3 |
Biological processes related to nicotine dependence according to GeneDecks: (show top 50)
(show all 65)
| id | Name | GO ID | Score | Top Affiliating Genes | | 1 | behavioral response to nicotine | GO:035095 | 10.6 | CHRNB1, CHRNA5, CHRNA4, CHRNB2, CHRNA3 | | 2 | synaptic transmission, cholinergic | GO:007271 | 10.6 | CHRNB3, CHRNB1, CHRNA4, CHRNB2, CHRNA3 | | 3 | serotonin biosynthetic process | GO:042427 | 10.5 | DDC, TPH2, TPH1 | | 4 | indolalkylamine biosynthetic process | GO:046219 | 10.5 | TPH2, DDC, TPH1 | | 5 | gamma-aminobutyric acid signaling pathway | GO:007214 | 10.5 | GABRA4, GABRA2, GABBR2, GABBR1 | | 6 | neurological system process | GO:050877 | 10.4 | CHRNB1, CHRNA4, CHRNB2 | | 7 | regulation of dopamine metabolic process | GO:042053 | 10.4 | SLC6A3, DRD4, DRD1, CHRNB2 | | 8 | phospholipase C-activating dopamine receptor signaling pathway | GO:060158 | 10.4 | DRD5, DRD2, DRD1 | | 9 | regulation of dopamine secretion | GO:014059 | 10.3 | DRD3, DRD2, CHRNA4, CHRNB2, CHRNA6 | | 10 | monoamine transport | GO:015844 | 10.3 | SLC18A2, SLC6A4, SLC6A3 | | 11 | response to histamine | GO:034776 | 10.3 | DRD4, DRD3, DRD2 | | 12 | behavioral response to ethanol | GO:048149 | 10.3 | DRD2, DRD4, DBH | | 13 | response to iron ion | GO:010039 | 10.3 | APBB1, DRD2, DBH, SLC6A3 | | 14 | dopamine biosynthetic process | GO:042416 | 10.3 | SLC6A3, TH, DDC | | 15 | regulation of dopamine uptake involved in synaptic transmission | GO:051584 | 10.3 | DRD3, DRD2, DRD1 | | 16 | adenylate cyclase-inhibiting dopamine receptor signaling pathway | GO:007195 | 10.3 | DRD4, DRD3, DRD2 | | 17 | fear response | GO:042596 | 10.3 | DBH, DRD4, BDNF | | 18 | G-protein coupled receptor internalization | GO:002031 | 10.2 | DRD3, DRD2, ARRB1, ARRB2 | | 19 | catecholamine biosynthetic process | GO:042423 | 10.2 | DBH, TH, DDC | | 20 | behavioral response to cocaine | GO:048148 | 10.2 | DRD4, DRD3, DRD2, DRD1 | | 21 | adenylate cyclase-activating dopamine receptor signaling pathway | GO:007191 | 10.2 | DRD5, DRD3, DRD1 | | 22 | negative regulation of adenylate cyclase activity | GO:007194 | 10.2 | GABBR2, GABBR1, DRD4, DRD3, DRD2, GRM2 | | 23 | dopamine metabolic process | GO:042417 | 10.1 | DRD4, DRD3, DRD2, DRD1 | | 24 | ion transport | GO:006811 | 10.1 | CHRNA2, SLC1A3, CHRNA4, CHRNB2, CHRNA3, CHRNA7 | | 25 | adult walking behavior | GO:007628 | 10.1 | DRD2, DRD1, ARRB2, CHAT | | 26 | negative regulation of blood pressure | GO:045776 | 10.1 | DRD5, DRD3, DRD2, CNR1 | | 27 | response to cocaine | GO:042220 | 10.0 | SLC18A2, SLC6A3, DRD5, DRD3, DRD2, CHRNB2 | | 28 | response to nicotine | GO:035094 | 10.0 | GABBR1, SLC6A3, DRD2, CHRNA4, CHRNB2, CHRNA7 | | 29 | negative regulation of protein secretion | GO:050709 | 10.0 | DRD4, DRD3, DRD2 | | 30 | synaptic transmission, dopaminergic | GO:001963 | 9.9 | TH, DRD5, DRD4, DRD3, DRD2, DRD1 | | 31 | visual learning | GO:008542 | 9.8 | DBH, PPP1R1B, DRD5, DRD3, DRD2, DRD1 | | 32 | response to amphetamine | GO:001975 | 9.8 | SLC18A2, DBH, PPP1R1B, DRD5, DRD4, DRD3 | | 33 | dopamine catabolic process | GO:042420 | 9.8 | MAOA, COMT, DBH, SLC6A3 | | 34 | circadian regulation of gene expression | GO:032922 | 9.8 | DRD3, DRD2, CARTPT | | 35 | dentate gyrus development | GO:021542 | 9.7 | PTEN, DRD1, BTG2 | | 36 | neurotransmitter biosynthetic process | GO:042136 | 9.6 | SLC6A3, TH, COMT, MAOA | | 37 | learning or memory | GO:007611 | 9.6 | SHC3, PTEN, DRD3, BDNF | | 38 | response to hypoxia | GO:001666 | 9.6 | SLC6A4, TH, DRD2, CHRNA4, CHRNB2, CHAT | | 39 | response to ethanol | GO:045471 | 9.4 | GABBR1, SLC6A3, TH, DRD3, MAOB, GRIN3A | | 40 | memory | GO:007613 | 9.4 | SLC6A4, DBH, TH, DRD1, CHRNB2, CHAT | | 41 | prepulse inhibition | GO:060134 | 9.3 | SLC6A3, NRXN1, PTEN, DRD3, DRD2, DRD1 | | 42 | locomotory behavior | GO:007626 | 9.3 | TH, DBH, SLC6A3, SLC18A2, PTEN, DRD3 | | 43 | positive regulation of excitatory postsynaptic membrane potential | GO:2000463 | 9.3 | DLG4, PTEN, NRXN1 | | 44 | signal transduction | GO:007165 | 9.2 | PPP1R1B, NR4A2, HINT1, ADCY1, CHRNA2, CHRNA5 | | 45 | social behavior | GO:035176 | 9.2 | SLC6A4, DBH, NRXN1, PTEN, DRD4, DRD3 | | 46 | xenobiotic metabolic process | GO:006805 | 8.5 | COMT, CYP2D6, CYP2E1, CYP2A6, MAOB, MAOA | | 47 | learning | GO:007612 | 8.4 | TH, COMT, NRXN1, NTRK2, DLG4, DRD3 | | 48 | response to drug | GO:042493 | 8.4 | COMT, SLC6A3, SLC1A3, SLC6A4, ADCY1, DRD3 | | 49 | synaptic transmission | GO:007268 | 7.9 | CHRNA6, SLC18A2, ADCY1, GABARAP, GABBR1, GABBR2 | | 50 | small molecule metabolic process | GO:044281 | 7.1 | CYP2E1, CYP2D6, COMT, TH, DBH, ADCY1 |
Molecular functions related to nicotine dependence according to GeneDecks: (show all 15)
| id | Name | GO ID | Score | Top Affiliating Genes | | 1 | ligand-gated ion channel activity | GO:015276 | 10.4 | CHRNB1, CHRNA5, CHRNA4, CHRNB2, CHRNA3 | | 2 | angiotensin receptor binding | GO:031701 | 10.2 | ARRB1, ARRB2 | | 3 | dopamine receptor activity | GO:004952 | 10.2 | DRD5, DRD4, DRD1 | | 4 | monoamine transmembrane transporter activity | GO:008504 | 10.2 | SLC6A3, SLC6A4, SLC18A2 | | 5 | tryptophan 5-monooxygenase activity | GO:004510 | 10.2 | TPH2, TPH1 | | 6 | acetylcholine binding | GO:042166 | 10.2 | CHRNB3, CHRNB1, CHRNA5, CHRNA4, CHRNB2, CHRNA3 | | 7 | acetylcholine receptor activity | GO:015464 | 10.2 | CHRNB1, CHRNA5, CHRNA2, CHRNA4, CHRNB2, CHRNA3 | | 8 | amino acid binding | GO:016597 | 10.2 | TPH1, TPH2, DDC | | 9 | dopamine receptor activity, coupled via Gi/Go | GO:001591 | 10.1 | DRD4, DRD3, DRD2 | | 10 | serotonin transmembrane transporter activity | GO:015222 | 10.1 | SLC18A2, SLC6A4 | | 11 | acetylcholine-activated cation-selective channel activity | GO:004889 | 10.0 | CHRNA6, CHRNA9, CHRNB3, CHRNA7, CHRNA3, CHRNB2 | | 12 | dopamine receptor activity, coupled via Gs | GO:001588 | 9.9 | DRD5, DRD1 | | 13 | dopamine binding | GO:035240 | 9.9 | SLC6A3, DRD5, DRD4, DRD3, DRD2, DRD1 | | 14 | iron ion binding | GO:005506 | 9.4 | TH, CYP2D6, CYP2E1, CYP2A6, TPH2, TPH1 | | 15 | drug binding | GO:008144 | 9.1 | SLC18A2, SLC6A3, CYP2D6, DRD5, DRD4, DRD3 |
|